View in EDS HTML Full Text PDF Full Text

Correction: Feemster et al. Implications of Cross-Reactivity and Cross-Protection for Pneumococcal Vaccine Development. Vaccines 2024, 12, 974.

Saved in:
Bibliographic Details
Title: Correction: Feemster et al. Implications of Cross-Reactivity and Cross-Protection for Pneumococcal Vaccine Development. Vaccines 2024, 12, 974.
Authors: Feemster K; Merck & Co., Inc., Rahway, NJ 07065, USA., Hausdorff WP; Center for Vaccine Innovation and Access, PATH, 455 Massachusetts Ave NW, Washington, DC 20001, USA.; Faculty of Medicine, Université Libre de Bruxelles, 1050 Brussels, Belgium., Banniettis N; Merck & Co., Inc., Rahway, NJ 07065, USA., Platt H; Merck & Co., Inc., Rahway, NJ 07065, USA., Velentgas P; Merck & Co., Inc., Rahway, NJ 07065, USA., Esteves-Jaramillo A; Merck & Co., Inc., Rahway, NJ 07065, USA., Burton RL; SunFire Biotechnologies LLC, Birmingham, AL 35203, USA., Nahm MH; Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL 35233, USA., Buchwald UK; Merck & Co., Inc., Rahway, NJ 07065, USA.
Source: Vaccines [Vaccines (Basel)] 2025 Aug 04; Vol. 13 (8). Date of Electronic Publication: 2025 Aug 04.
Publication Type: Published Erratum
Journal Info: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101629355 Publication Model: Electronic Cited Medium: Print ISSN: 2076-393X (Print) Linking ISSN: 2076393X NLM ISO Abbreviation: Vaccines (Basel) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40872973
AccessLevel: 2
PubTypeId: unknown
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Correction: Feemster et al. Implications of Cross-Reactivity and Cross-Protection for Pneumococcal Vaccine Development. Vaccines 2024, 12, 974.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Feemster+K%22">Feemster K</searchLink>; Merck & Co., Inc., Rahway, NJ 07065, USA.<br /><searchLink fieldCode="AU" term="%22Hausdorff+WP%22">Hausdorff WP</searchLink>; Center for Vaccine Innovation and Access, PATH, 455 Massachusetts Ave NW, Washington, DC 20001, USA.; Faculty of Medicine, Université Libre de Bruxelles, 1050 Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Banniettis+N%22">Banniettis N</searchLink>; Merck & Co., Inc., Rahway, NJ 07065, USA.<br /><searchLink fieldCode="AU" term="%22Platt+H%22">Platt H</searchLink>; Merck & Co., Inc., Rahway, NJ 07065, USA.<br /><searchLink fieldCode="AU" term="%22Velentgas+P%22">Velentgas P</searchLink>; Merck & Co., Inc., Rahway, NJ 07065, USA.<br /><searchLink fieldCode="AU" term="%22Esteves-Jaramillo+A%22">Esteves-Jaramillo A</searchLink>; Merck & Co., Inc., Rahway, NJ 07065, USA.<br /><searchLink fieldCode="AU" term="%22Burton+RL%22">Burton RL</searchLink>; SunFire Biotechnologies LLC, Birmingham, AL 35203, USA.<br /><searchLink fieldCode="AU" term="%22Nahm+MH%22">Nahm MH</searchLink>; Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL 35233, USA.<br /><searchLink fieldCode="AU" term="%22Buchwald+UK%22">Buchwald UK</searchLink>; Merck & Co., Inc., Rahway, NJ 07065, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101629355%22">Vaccines</searchLink> [Vaccines (Basel)] 2025 Aug 04; Vol. 13 (8). <i>Date of Electronic Publication: </i>2025 Aug 04.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Published Erratum
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22MDPI+AG%22">MDPI AG </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101629355 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2076-393X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222076393X%22">2076393X </searchLink><i>NLM ISO Abbreviation: </i>Vaccines (Basel) <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40872973
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3390/vaccines13080831
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Correction: Feemster et al. Implications of Cross-Reactivity and Cross-Protection for Pneumococcal Vaccine Development. Vaccines 2024, 12, 974.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Feemster K
      – PersonEntity:
          Name:
            NameFull: Hausdorff WP
      – PersonEntity:
          Name:
            NameFull: Banniettis N
      – PersonEntity:
          Name:
            NameFull: Platt H
      – PersonEntity:
          Name:
            NameFull: Velentgas P
      – PersonEntity:
          Name:
            NameFull: Esteves-Jaramillo A
      – PersonEntity:
          Name:
            NameFull: Burton RL
      – PersonEntity:
          Name:
            NameFull: Nahm MH
      – PersonEntity:
          Name:
            NameFull: Buchwald UK
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 04
              M: 08
              Text: 2025 Aug 04
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 2076-393X
          Numbering:
            – Type: volume
              Value: 13
            – Type: issue
              Value: 8
          Titles:
            – TitleFull: Vaccines
              Type: main
ResultId 1